ciprofloxacin has been researched along with 2-acetylaminofluorene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahr, HJ; Brendler-Schwaab, SY; Herbold, BA | 1 |
| Itoh, T; Mitsumori, K; Moto, M; Sakai, H; Takahashi, M | 1 |
2 other study(ies) available for ciprofloxacin and 2-acetylaminofluorene
| Article | Year |
|---|---|
Ciprofloxacin: in vivo genotoxicity studies.
Topics: 2-Acetylaminofluorene; Animals; Area Under Curve; Bone Marrow Cells; Chromosome Aberrations; Ciprofloxacin; Cricetinae; Cytogenetic Analysis; DNA; Dose-Response Relationship, Drug; Female; Hepatocytes; Male; Mice; Micronucleus Tests; Mutagenicity Tests; Rats; Rats, Inbred F344; Thymidine; Toxicity Tests, Acute | 2001 |
Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats.
Topics: 2-Acetylaminofluorene; Animals; Anti-Infective Agents; Carbon Tetrachloride; Carcinogens; Ciprofloxacin; Glutathione Transferase; Liver; Male; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred F344 | 2006 |